Skip to main content
TipRanks
Go Ultimate75% OFF

Modalis Therapeutics Corporation (4883) Stock Statistics & Valuation Metrics

3 Followers

Total Valuation

Modalis Therapeutics Corporation has a market cap or net worth of JPY 3.73B. The enterprise value is JPY 842.94M.

Market Cap
JPY 3.73B
Enterprise Value
JPY 842.94M

Share Statistics

Modalis Therapeutics Corporation has 115,954,100 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
115,954,100
Owned by Insiders
―
Owned by Institutions
―

Financial Efficiency

Modalis Therapeutics Corporation’s return on equity (ROE) is -0.77 and return on invested capital (ROIC) is -78.17%.

Return on Equity (ROE)
-0.77
Return on Assets (ROA)
-0.73
Return on Invested Capital (ROIC)
-78.17%
Return on Capital Employed (ROCE)
-0.78
Revenue Per Employee
0
Profits Per Employee
-126.63M
Employee Count
17
Asset Turnover
0.00
Inventory Turnover
0.00

Valuation Ratios

The current PE Ratio of Modalis Therapeutics Corporation is -1.41. Modalis Therapeutics Corporation’s PEG ratio is -0.05.

PE Ratio
-1.41
PS Ratio
0.00
PB Ratio
1.30
Price to FCF
0.00
Price to Operating Cash Flow
0.00
PEG Ratio
-0.05

Income Statement

In the last 12 months, Modalis Therapeutics Corporation had revenue of 0 and earned -2.15B in profits. Earnings per share was -27.86.

Revenue
0
Gross Profit
0
Operating Income
-2.21B
Pretax Income
-2.15B
Net Income
-2.15B
EBITDA
-2.21B
Earnings Per Share (EPS)
-27.86

Cash Flow

In the last 12 months, operating cash flow was 0 and capital expenditures 0, giving a free cash flow of 0 billion.

Operating Cash Flow
0
Free Cash Flow
0
Free Cash Flow per Share
0.00

Dividends & Yields

Modalis Therapeutics Corporation pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
0.00%
Earnings Yield
-61.34%

Stock Price Statistics

Beta
0.92
52-Week Price Change
-53.73%
50-Day Moving Average
30.52
200-Day Moving Average
42.65
Relative Strength Index (RSI)
47.88
Average Volume (3m)
1.89M

Important Dates

Modalis Therapeutics Corporation upcoming earnings date is Feb 15, 2027, TBA (Not Confirmed).

Last Earnings Date
Nov 12, 2026
Next Earnings Date
Feb 15, 2027
Ex-Dividend Date
―

Financial Position

Modalis Therapeutics Corporation as a current ratio of 21.46, with Debt / Equity ratio of 0.00%

Current Ratio
21.46
Quick Ratio
21.46
Debt to Market Cap
0.00
Net Debt to EBITDA
1.27
Interest Coverage Ratio
-788.80

Taxes

In the past 12 months, Modalis Therapeutics Corporation has paid 1.54M in taxes.

Income Tax
1.54M
Effective Tax Rate
-0.00

Enterprise Valuation

Modalis Therapeutics Corporation EV to EBITDA ratio is -0.59, with an EV/FCF ratio of 0.00.

EV to Sales
0.00
EV to EBITDA
-0.59
EV to Free Cash Flow
0.00
EV to Operating Cash Flow
0.00

Balance Sheet

Modalis Therapeutics Corporation has JPY 3.02B in cash and marketable securities with JPY 270.00M in debt, giving a net cash position of JPY 2.75B billion.

Cash & Marketable Securities
JPY 3.02B
Total Debt
JPY 270.00M
Net Cash
JPY 2.75B
Net Cash Per Share
JPY 23.68
Tangible Book Value Per Share
JPY 26.10

Margins

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

Gross Margin
0.00%
Operating Margin
0.00%
Pretax Margin
0.00%
Net Profit Margin
0.00%
EBITDA Margin
0.00%
EBIT Margin
0.00%

Analyst Forecast

The average price target for Modalis Therapeutics Corporation is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
―
EPS Growth Forecast
25.34%

Scores

Smart Score
―
AI Score
43